References
- Johnson S, et al. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning.[see comment]. J Assoc Physicians India. 1996; 44(8): 529–31.
- Vardi A, et al. Intraosseous vascular access in the treatment of chemical warfare casualties assessed by advanced simulation: proposed alteration of treatment protocol. Anesth Analg. 2004; 98(6): 1753–8, table of contents.
- Goransson-Nyberg A, et al. Treatment of organophosphate poisoning in pigs: antidote administration by a new binary autoinjector. Arch Toxicol. 1995; 70(1): 20–7.
- Kore G. Therapeutic drug monitoring principles in the neonate. Natl Acad Clin Biochem Clin Chem. 1997; 43(1): 222–7.
- Dubick MA, Atkins JL Small-volume fluid resuscitation for the far-forward combat environment: current concepts. J Trauma-Injury Infect Crit Care. 2003; 54(5 Suppl): S43–5.
- Haas NA. Clinical review: vascular access for fluid infusion in children. Crit Care (London, England). 2004; 8(6): 478–84.
- Khan TM, et al. Comparison of plasma levels and pharmacodynamics after intraosseous and intravenous administration of fosphenytoin and phenytoin in piglets. Pediatr Crit Care Med. 2000; 1(1): 60–4.
- LaRocco B, Wang H., Intraosseous infusion. Prehosp Emerg Care. 2003; 7(2): 280–5.
- Smith R, et al. The utilisation of intraosseous infusion in the resuscitation of paediatric major trauma patients. Injury. 2005; 36(9): 1034–8; discussion 1039.
- American Heart Association. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support. Pediatrics. 2006; 117(5): e1005–28.
- Reades R, et al. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011; 58(6): 509–16.
- Wampler D, et al. Paramedics successfully perform humeral EZ-IO intraosseous access in adult out-of-hospital cardiac arrest patients. Am J Emerg Med. 2012; 30(7): 1095–9.
- Ko JC, et al. Comparison of Telazol, Telazol–ketamine, Telazol–xylazine, and Telazol–ketamine–xylazine as chemical restraint and anesthetic induction combination in swine. Lab Anim Scie. 1993; 43(5): 476–80.
- Shiloff JD, Clement JG. Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats. Toxicol Appl Pharmacol. 1987; 89(2): 278–80.
- Haneda K, Horiuchi T. A method for measurement of total circulating blood volume using indocyanine green. Tohoku J Exp Med. 1986; 148(1): 49–56.
- Katz KD, et al. Toxicity, Organophosphate. eMedicine from WebMD; www.emedicine.com/med/topic1677.htm, 2006.
- Schexnayder S, et al. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol. 1998; 36(6): 549–55.
- Murray DB, et al. Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration. Ann Emerg Med. 2012; 60(4): 424–30.
- Dubick MA, Holcomb JB. A review of intraosseous vascular access: current status and military application. Mil Med. 2000; 165(7): 552–9.
- Leidel BA, et al. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012; 83(1): 40–5.
- Santos D, et al. EZ-IO((R)) intraosseous device implementation in a pre-hospital emergency service: a prospective study and review of the literature. Resuscitation. 2013; 84(4): 440–5.
- Pozza M, Lunardi, F, Pflipsen M. Emergency intraosseous access: a useful, lifesaving device used in afghanistan. J Spec Oper Med. 2013; 13(1): 25–8.
- Orlowski J, et al. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusion of emergency drugs. Am J Dis Children. 1990; 144(1): 112–7.
- Eisenkraft A, et al. Efficacy of the bone injection gun in the treatment of organophosphate poisoning. Biopharm Drug Dispos. 2007; 28(3): 145–50.